Results 21 to 30 of about 36,976 (227)

Aortic valve surgery for aortic regurgitation caused by Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome: a case report

open access: yesJournal of Cardiothoracic Surgery, 2021
Background Antiphospholipid syndrome is an antibody mediated pro-thrombotic state leading to various arterial and venous thromboses. The syndrome can be either primary or secondary to other autoimmune diseases, commonly systemic lupus erythematosus ...
Yan Le Ho   +3 more
doaj   +1 more source

Recurrent Cerebral Artery Dissection Associated with Seronegative Antiphospholipid Antibody Syndrome

open access: yesTomography, 2022
Stroke in young patients requires thorough evaluation as they often lack risk factors. Antiphospholipid syndrome can cause arterial thrombosis and pregnancy loss; hence, differential diagnoses should include seronegative antiphospholipid syndrome.
Hee Sue Kim   +3 more
doaj   +1 more source

Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study [PDF]

open access: yes, 2017
BACKGROUND: Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is caused by antiphospholipid antibodies. Anticardiolipin antibodies, anti-β2 glycoprotein-I, and lupus anticoagulant are the main autoantibodies found in ...
Visentin S   +20 more
core   +4 more sources

RETROSPECTIVE ANALYSIS OF MEDICAL CHARTS OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

open access: yesМедична наука України, 2023
Background. Antiphospholipid attracts the attention of clinicians in various fields of medicine. This pathology is characterized by a triad of clinical and laboratory signs: recurrent venous or arterial thrombosis with localization in any part of the ...
V. I. Savytskyi
doaj   +1 more source

Antiphospholipid Syndrome

open access: yesJournal of Investigative Dermatology, 1993
The antiphospholipid antibodies (aPL), namely, the lupus anticoagulant and the anticardiolipin antibodies, are a family of autoantibodies directed predominantly against negatively charged phospholipids. Many studies have confirmed that patients with these antibodies are prone to repeated episodes of thrombosis, fetal losses, and thrombocytopenia.
Asherson, Ronald A., Cervera, Ricard
openaire   +2 more sources

A role for uric acid and the nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast [PDF]

open access: yes, 2013
Women with antiphospholipid syndrome (APS) are at risk of recurrent pregnancy loss and obstetrical disorders, such as preeclampsia and intrauterine growth restriction (IUGR).
Vikki M Abrahams   +13 more
core   +1 more source

The Antiphospholipid Syndrome [PDF]

open access: yesSeminars in Nephrology, 2007
The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the clinical association of antiphospholipid autoantibodies (aPL) with a syndrome of hypercoagulability that can affect any blood vessel, irrespective of type or size. Involvement of larger vessels, such as arteries or veins, manifests in the form of thrombosis or embolism ...
Michael J, Fischer   +2 more
openaire   +2 more sources

Patients with Essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis [PDF]

open access: yes, 2002
A significant proportion of patients with Essential Thrombocythaemia (ET) have thrombotic complications which have an important impact upon the quality, and duration of their life.
Machin, S.J.   +11 more
core   +1 more source

Catastrophic antiphospholipid syndrome presenting as fever of unknown origin

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2012
Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies with characteristic clinical manifestation, which include venous, arterial thrombosis, thrombotic microangiopathy, and recurrent fetal loss.
Fatma I Al-Beladi
doaj   +1 more source

Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2023
COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome.
Lauren Bitterman MD   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy